Drug intelligence / Profile preview

NCD-1001

Development stage
Unknown
Lead developer
Nocendra
Administration
Topical
01

Overview

NCD-1001 (IsoDent Paro) is a topical oral rinse developed by Nocendra for the management of inflammatory oral conditions, including periodontitis, gingivitis, peri-implantitis, and oral mucositis. Unlike traditional antimicrobial mouthwashes that focus on direct bacterial killing, NCD-1001 utilizes a patented Cl-Dextran resolution medium. This approach is based on the biology of Specialized Pro-resolving Mediators (SPMs), which actively modulate the host's tissue response to promote the resolution of inflammation and facilitate tissue repair. By stimulating the resolution phase of the innate immune response, NCD-1001 helps restore homeostasis in the oral cavity without the use of conventional antibiotics or antiseptics. It is currently approved and marketed for dental and oral care applications.

Brand names
IsoDent Paro
Other names
Cl-DextranCl-Dextran resolution medium

Beyond the preview

Go deeper on NCD-1001.

Explore the evidence, development activity, and competitive landscape with Gosset’s full data platform.

Clinical trials

Full profile access

Follow clinical development from study design and recruitment through results.

  • Trial phase
  • Status
  • Readouts

Indications & development

Full profile access

Explore development by indication, patient population, and geography.

  • Indications
  • Development status
  • Countries

Licensing & deals

Full profile access

Trace asset ownership, licensing agreements, and commercial partnerships.

  • Partners
  • Deal terms
  • Milestones

Patents & exclusivity

Full profile access

Explore the patent landscape and regulatory exclusivity around an asset.

  • Patents
  • Expiration dates
  • Exclusivity

Competitive landscape

Full profile access

Compare development programs by target, modality, and indication.

  • Competing assets
  • Targets
  • Development stage

Research & analysis

Full profile access

Connect source evidence and development news to your research questions.

  • Publications
  • News
  • Analysis

Bring the full picture into focus.

See how Gosset can support your research on NCD-1001.

Explore the full profile

Gosset Free

Get started with Gosset.

Enter your work email and we’ll be in touch with next steps.

Work email preferred.

Book a call